Publications

5674 Results

Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): estimates from a Southwest Oncology Group Clinical Trial

Authors
CL Bennett;D Hynes;J Godwin;TJ Stinson;RM Golub;FR Appelbaum
Journal / Conference
Cancer Investigation 19(6):603-610
Year
2001
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia. a Southwest Oncology Group study

Authors
AF List;KJ Kopecky;CL Willman;DR Head;DL Persons;ML Slovak;R Dorr;C Karanes;HE Hynes;JH Doroshow;M Shurafa;FR Appelbaum
Journal / Conference
Blood 98(12):3212-3220
Year
2001
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9126

Association of African American ethnic background with survival in men with metastatic prostate cancer.

Authors
IM Thompson;CM Tangen;A Tolcher;ED Crawford;M Eisenberger;CM Moinpour
Journal / Conference
Journal of the National Cancer Institute 93(3):219-225
Year
2001
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis

Authors
SM Garrido;JJ Cooper;FR Appelbaum;CL Willman;K Kopecky;DE Banker
Journal / Conference
Leukemia Research 25:23-32
Year
2001
Research Committee(s)
Leukemia

Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group study

Authors
MHA Hussain;TR Glass;J Forman;W Sakr;DC Smith;M Al-Sarraf;J Jones;SP Balcerzak;ED Crawford;HB Grossman
Journal / Conference
Journal of Urology 165:56-61
Year
2001
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9312

Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a lab ancillary study on an Eastern Cooperative Oncology Group prospective randomized trial of postop adjuvant therapy

Authors
JH Schiller;S Adak;RH Feins;SM Keller;WA Fry;RB Livingston;MEM Hammond;B Wolf;L Sabatini;J Jett;L Kohman;DH Johnson
Journal / Conference
Journal of Clinical Oncology 19(2):448-457
Year
2001
Research Committee(s)
Lung
Study Number(s)
SWOG-9323 (E4592)

Impact of therapy with chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011

Authors
VA Morrison;KR Rai;BL Peterson;JE Kolitz;L Elias;FR Appelbaum;JD Hines;L Shepherd;RE Martell;RA Larson;CA Schiffer
Journal / Conference
Journal of Clinical Oncology 19(16):3611-3621
Year
2001
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9108 (CALGB-9011)

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small volume stage III ovarian carcinoma: An intergroup stud y of the GOG, SWOG, and ECOG

Authors
M Markman;BN Bundy;DS Alberts;JM Fowler;DL Clark-Pearson;LF Carson;S Wadler;J Sickel
Journal / Conference
Journal of Clinical Oncology 19(4):1001-1007
Year
2001
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9227 (GOG-114)

Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group study

Authors
SH Petersdorf;KJ Kopecky;DR Head;DH Boldt;SP Balcerzak;T Wun;V Roy;RW Veith;FR Appelbaum
Journal / Conference
Leukemia 15:208-216
Year
2001
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8417/19

Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy: a Southwest Oncology Group Study

Authors
RP Whitehead;JM Unger;LE Flaherty;JR Eckardt;SA Taylor;MS Didolkar;W Samlowski;VK Sondak
Journal / Conference
Investigational New Drugs 19:239-243
Year
2001
Research Committee(s)
Melanoma
Study Number(s)
S9622